• US 20160151331A1
  • Filed: 02/05/2016
  • Published: 06/02/2016
  • Est. Priority Date: 03/20/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating depression, inflammatory skin disease, psoriasis, atopic dermatitis, contact dermatitis, rheumatoid arthritis, osteoarthritis, systemic lupus erythrematosus, inflammatory bowel disease, Crohn'"'"'s Disease, Bechet'"'"'s Disease or colitis which comprises administering to a patient in need of such treatment a therapeutically effective amount of stereomerically pure (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, or a pharmaceutically acceptable prodrug, polymorph, salt, or solvate thereof.

View all claims

    Thank you for your feedback